Latest News about Multidisciplinary Association for Psychedelic Studies
Recent news which mentions Multidisciplinary Association for Psychedelic Studies
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
November 20, 2024
Tickers
NEWS
From Benzinga
Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?
November 06, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
August 29, 2024
From Benzinga
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
June 24, 2024
From Benzinga
MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy
June 03, 2024
Tickers
NEWS
From Benzinga
From Benzinga
NFL's Jon Feliciano Takes His Psychedelics Advocacy To The Field: Chooses MAPS As His "My Cleats, My Cause"
December 05, 2023
From Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
From Benzinga
From Benzinga
Burning Man CEO Learned 'So Much' About Psychedelics In BRC: 'We're Here For The Love'
June 30, 2023
Tickers
TSLA
From Benzinga
World's Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees
June 26, 2023
Tickers
KONEF
From Benzinga
Psychedelic Science 101: Dr. Huberman Calls On Academics To Have 'The Guts To Take On Something Risky'
June 22, 2023
From Benzinga
MAPS' Psychedelic Science 2023: Gov. Polis To Open Event, New Shulgin Compounds To Be Revealed
June 14, 2023
Tickers
ATAI
From Benzinga
The Flaming Lips, Eric Andre & Reggie Watts And Many More At MAPS 2023 Psychedelic Event
May 18, 2023
Tickers
NFLX
From Benzinga
MDMA Therapy For PTSD Nearing Legalization In US And Worldwide, MAPS Releases Promising Data
April 05, 2023
From Benzinga
Psychedelic Science 2023: Details On Agenda And Acclaimed Speakers At MAPS Annual Gathering
March 10, 2023
From Benzinga
Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
January 30, 2023
From Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
From Benzinga
MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD
September 14, 2022
From Benzinga
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say
May 20, 2022
From Benzinga
DEA Under Fire For Blocking Psilocybin As Treatment For Terminally Ill Cancer Patients
April 14, 2022
From Benzinga
Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms
November 22, 2021
Tickers
FTRP
From Benzinga
Australian Psychiatrist Sues State Of Victoria For Denying MDMA Treatment For Ailing Patient
November 17, 2021
From Benzinga
Tickers
TC
From TechCrunch
Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out
September 14, 2021
Tickers
WSNAF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.